News | May 30, 2012

Bayer Healthcare Will Exhibit New Nuclear Imaging Technologies at SNM 2012

Bayer Healthcare  Will Exhibit New Nuclear Imaging Technologies at SNM 2012

May 30, 2012 — Bayer Radiology & Interventional will showcase new device technologies at the annual meeting of the Society of Nuclear Medicine (SNM) in Miami, June 9-13. The new technology includes enhancements to the Intego PET (positron emission tomography) Infusion System, as well as developing platforms for controlled administration of molecular agents for SPECT (single photon emission computed tomography) and small animal imaging procedures.

In PET, the Medrad Intego System is a worldwide market leader and the only U.S. Food and Drug Administration (FDA) -cleared system for administration of 18F-FDG and 18F-NaF. Bayer has continued to innovate and evolve the Intego platform since its launch in 2008, including adding software features, expanding compatibility and indications, and significantly reducing the size of the device. At SNM, Bayer plans to demonstrate Certegra informatics solutions for Intego, including wireless integration to HIS (hospital information system), RIS (radiology information system) and PACS (picture archiving and communications system) that facilitate downloading the PET modality worklist as an infusion schedule and sending infusion results to PACS. This new capability will replace several manual processes, which in turn will streamline workflow and improve efficiency for PET imaging clinics.

"Automated, controlled injection of molecular agents not only has safety and workflow benefits for staff, it can lead to improvements in patient care and help clinicians and scientists unlock the potential of molecular medicine," said Doug Descalzi, senior director of molecular imaging devices for Bayer.

In addition the company will showcase developing technologies for controlled administration of low energy radiopharmaceuticals and for small animal molecular imaging.

For more information: www.bayerhealthcare.com

Related Content

Brazil's Santa Casa Hospital System Chooses Carestream for Unified Diagnostic Workflow
News | PACS | May 22, 2019
Santa Casa de Misericordia has selected Carestream to replace its legacy diagnostic workflow technology across all...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
FDA Approves Zebra Medical Vision's HealthPNX AI Chest X-ray Triage Product
Technology | Artificial Intelligence | May 13, 2019
Zebra Medical Vision has received U.S. Food and Drug Administration (FDA) 510(k) clearance for HealthPNX, an artificial...
Shine Medical Technologies Breaks Ground on U.S. Medical Isotope Production Facility

Image courtesy of Amen Clinics

News | Radiopharmaceuticals and Tracers | May 10, 2019 | Jeff Zagoudis, Associate Editor
Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S...
A 3-D printed tungsten X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | April 29, 2019 | By Steve Jeffery
In ...
Cambridge University Hospitals NHS Foundation Trust Implements Change Healthcare Enterprise Imaging
News | Enterprise Imaging | April 15, 2019
Change Healthcare successfully implemented its Radiology PACS (picture archiving and communication system), Image...
Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of...
vRad Receives 19th Patent
News | Teleradiology | April 10, 2019
vRad (Virtual Radiologic), a Mednax Radiology Solutions practice, announced that the U.S. Patent and Trademark Office...
Visage 7 Enterprise Imaging Platform Highlighted at 2019 SBI/ACR Breast Imaging Symposium
News | Enterprise Imaging | April 05, 2019
Visage Imaging will be exhibiting the latest version of the Visage 7 Enterprise Imaging Platform at the 2019 Society of...